Dados B3 › MAPT4 × CSUD3
MAPT4 × CSUD3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | MAPT4 | CSUD3 | year |
|---|---|---|---|
| ROE | — | 0.0% | no year where both have it |
| ROIC | — | 22.3% | no year where both have it |
| ROA | -13.3%! | 14.7% | 2025 |
| Gross margin | — | 41.4% | no year where both have it |
| EBIT margin | — | 18.1% | no year where both have it |
| Net margin | — | 17.0% | no year where both have it |
| Net debt/EBITDA | — | 0.27x | no year where both have it |
| Current ratio | 0.00x! | 1.48x | 2025 |
| Revenue growth (1y) | — | 9.8% | no year where both have it |
| Revenue growth (5y CAGR) | — | 6.4%! | no year where both have it |
| Piotroski F-Score | 2/9! | 7/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | MAPT4 | CSUD3 | year |
|---|---|---|---|
| P/E | -27.66x | — | 2025 |
| P/B | — | 1.65x | 2025 |
| EV/EBITDA | — | 4.67x | 2025 |
| FCF yield | — | 6.6% | 2025 |
Numbers on this page are live. Data version 2026-09-01-supressao-declarada · page generated 2026-09-09 15:38 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.